This midostaurin drug-drug interaction study assessed the dynamic response and clinical usefulness of urinary @-hydroxycortisol to cortisol ratio ( @CR ) and plasma @-hydroxycholesterol ( @HC ) for monitoring CYP@A@ activity in the presence or absence of rifampicin , a strong CYP@A@ inducer .